THAP11F80L cobalamin disorder-associated mutation reveals normal and pathogenic THAP11 functions in gene expression and cell proliferation.

Détails

Ressource 1Télécharger: 31905202_BIB_C37EB953998B.pdf (1871.47 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_C37EB953998B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
THAP11F80L cobalamin disorder-associated mutation reveals normal and pathogenic THAP11 functions in gene expression and cell proliferation.
Périodique
PloS one
Auteur(s)
Dehaene H., Praz V., Lhôte P., Lopes M., Herr W.
ISSN
1932-6203 (Electronic)
ISSN-L
1932-6203
Statut éditorial
Publié
Date de publication
2020
Peer-reviewed
Oui
Volume
15
Numéro
1
Pages
e0224646
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Twelve human THAP proteins share the THAP domain, an evolutionary conserved zinc-finger DNA-binding domain. Studies of different THAP proteins have indicated roles in gene transcription, cell proliferation and development. We have analyzed this protein family, focusing on THAP7 and THAP11. We show that human THAP proteins possess differing homo- and heterodimer formation properties and interaction abilities with the transcriptional co-regulator HCF-1. HEK-293 cells lacking THAP7 were viable but proliferated more slowly. In contrast, HEK-293 cells were very sensitive to THAP11 alteration. Nevertheless, HEK-293 cells bearing a THAP11 mutation identified in a patient suffering from cobalamin disorder (THAP11F80L) were viable although proliferated more slowly. Cobalamin disorder is an inborn vitamin deficiency characterized by neurodevelopmental abnormalities, most often owing to biallelic mutations in the MMACHC gene, whose gene product MMACHC is a key enzyme in the cobalamin (vitamin B12) metabolic pathway. We show that THAP11F80L selectively affected promoter binding by THAP11, having more deleterious effects on a subset of THAP11 targets, and resulting in altered patterns of gene expression. In particular, THAP11F80L exhibited a strong effect on association with the MMACHC promoter and led to a decrease in MMACHC gene transcription, suggesting that the THAP11F80L mutation is directly responsible for the observed cobalamin disorder.
Mots-clé
Cell Line, Cell Proliferation/genetics, Chromosomal Proteins, Non-Histone/genetics, DNA-Binding Proteins/genetics, Gene Expression Regulation/genetics, HEK293 Cells, Host Cell Factor C1/genetics, Humans, Metabolic Networks and Pathways/genetics, Mutation/genetics, Oxidoreductases/genetics, Promoter Regions, Genetic, Protein Binding/genetics, Repressor Proteins/genetics, Vitamin B 12/genetics, Vitamin B 12/metabolism, Vitamin B 12 Deficiency/genetics, Vitamin B 12 Deficiency/metabolism, Vitamin B 12 Deficiency/pathology
Pubmed
Open Access
Oui
Création de la notice
10/01/2020 15:47
Dernière modification de la notice
30/04/2021 7:14
Données d'usage